ASU Biodesign scientists develop improved, potentially safer Zika vaccine
ASU Biodesign Institute scientist Qiang "Shawn" Chen has led his research team to develop the world's first plant-based Zika vaccine that could be more potent, safer and cheaper to produce than any other efforts to date. "We are very excited about these results."Rapid response networkSeveral potential Zika vaccines have had promising results in early animal and human tests. Last year, the Food and Drug Administration approved the first human testing of a Zika vaccine candidate, and this summer, a $100 million U.S. government-led clinical trial is underway. They first grew the envelope protein in bacteria, then switched to prepare the DIII protein domain in tobacco plants. For the second research group, they used the complete Zika envelope protein for their vaccine.
ASU researcher says he's developed tobacco-based Zika virus vaccine
LISTEN: ASU researcher says he's developed tobacco-based Zika virus vaccine Your browser does not support the audio element. PHOENIX — A researcher at Arizona State University said Thursday that he has developed a tobacco plant-based vaccine for Zika virus. "I use a small part of DNA from the Zika protein [then] I put that DNA into tobacco plants," he said. Chen said the tobacco-based vaccine has benefits over traditional vaccines. Chen said he chose to develop the vaccine in tobacco plants because it is simple to direct foreign proteins into them.collected by :Lucy William
No comments:
Post a Comment